United Bank
Source: SEC Form 13F · as of Mar 2026United Bank holds 20 biotech & pharma companies tracked by BioSniper, totaling $73.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$73.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 70,193 | $17.2M |
| ABTABBOTT LABORATORIES | 139,034 | $14.3M |
| AMGNAMGEN INC | 36,272 | $12.8M |
| GILDGILEAD SCIENCES, INC. | 62,119 | $8.7M |
| LLYELI LILLY & Co | 4,527 | $4.2M |
| PFEPFIZER INC | 103,545 | $2.9M |
| BMYBRISTOL MYERS SQUIBB CO | 46,456 | $2.8M |
| CORCencora Inc. | 7,676 | $2.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 38,083 | $2.1M |
| ABBVAbbVie Inc. | 9,399 | $2.0M |
| ZBHZimmer Biomet Holdings Inc. | 14,856 | $1.3M |
| MRKMerck & Co., Inc. | 6,599 | $794K |
| DGXQuest Diagnostics Incorporated | 3,124 | $612K |
| IDXXIDEXX LABORATORIES INC /DE | 700 | $393K |
| TRVITrevi Therapeutics, Inc. | 31,200 | $372K |
| PMPhilip Morris International Inc | 1,372 | $227K |
| IBRXImmunityBio, Inc. | 14,300 | $110K |
| ZVRAZEVRA THERAPEUTICS, INC. | 10,564 | $98K |
| CRDFCardiff Oncology, Inc. | 22,411 | $36K |
| GNLXGENELUX Corp | 12,070 | $29K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.